South africa: From species cradle to genomic applications

Nature Reviews Genetics

Volumn 9, Issue , 2008, Pages S19-S23

  Hardy, Billie Jo ^a   Séguin, Béatrice ^a   Ramesar, Raj ^b   Singer, Peter A ^a,c   Daar, Abdallah S ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c MaRS Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICINE; ECONOMIC DEVELOPMENT; GENE MUTATION; GENETIC VARIABILITY; GENOMICS; HUMAN; HUMAN GENOME PROJECT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KNOWLEDGE BASE; MEDICAL RESEARCH; PHARMACOGENETICS; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; TUBERCULOSIS;

BIOTECHNOLOGY; GENOMICS; HUMANS; LEADERSHIP; POLITICS; SOUTH AFRICA;

EID: 52149092312     PISSN: 14710056     EISSN: 14710064     Source Type: Journal    
DOI: 10.1038/nrg2441     Document Type: Article

References (19)

1. Jakobsson, M.: Genotype, haplotype and copy-number variation in worldwide human populations. Nature 451,998-1003 (2008).
2. Li, J. Z.: Worldwide human relationships inferred from genome-wide patterns of variation. Science 319, 1100-1104 (2008).
3. Lohmueller, K. E.: Proportionally more deleterious genetic variation in European than in African populations. Nature 451,994-997 (2008).
4. Tishkoff, S. A. and Williams, S. M.: Genetic analysis of African populations: human evolution and complex disease. Nature Rev. Genet. 3, 611-621 (2002).
5. Séguin, B., Hardy, B., Singer, P A. and Daar, A. S.: Genomic medicine and developing countries: creating a room of their own. Nature Rev. Genet. 9, 487-493 (2008).
6. Séguin, B., Hardy, B., Singer, P A. and Daar, A. S.: Human genomic variation initiatives in emerging economies and developing countries. Nature Rev. Genet. 9 (Suppl), S3-S4 (2008).
7. Public Understanding of Biotechnology. National Biotechnology Strategy for South Africa [online], (2001).
8. Cloete, T. E., Nel, L. H. and Theron, J.: Biotechnology in South Africa. Trends Biotechnol. 24, 557-562 (2006).
9. Gastrow, M.: Great expectations: the state of biotechnology research and development in South Africa. African Journal of Biotechnology 7, 342-348 (2008).
10. Louet, S.: Rainbow biotech — South Africa’s emerging sector. Nature Biotechnol. 24, 1313-1316 (2006).
11. Motari, M.: South Africa — blazing a trail for African biotechnology. Nature Biotechnol. 22 (Suppl), DC37-DC41 (2004).
12. Hodgson, J.: South Africa seeks genomic partners. Nature Biotechnol. 19, 601-602 (2001).
13. Dixon, S., McDonald, S. and Roberts, J.: The impact of HIV and AIDS on Africa’s economic development. BMJ 324, 232-234 (2002).
14. Parathyras, J. B.: Molecular Genetic Analysis ofHuman Immunodeficiency Virus Antiretroviral Therapy Response in South Africa — a Pharmacogenetics Study. Thesis, Stellenbosch Univ. [online], (2008).
15. Babb, C.: Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis (Edinb.) 87, 295-302 (2007).
16. Barreiro, L. B.: Promoter variation in the DC-SIGN-encoding gene CD209 is associated with tuberculosis. PLoS Med. 3, e20 (2006).
17. Cooke, G. S.: Mapping of a novel susceptibility locus suggests a role for MC3R and CTSZ in human tuberculosis. Am. J. Respir. Crit. Care Med. 178, 203-207 (2008).
18. Department of Science and Technology. Innovation Towards a Knowledge-Based Economy Ten-Year Plan for South Africa (2008-2018). [online],< http://unpan1.un.org/intradoc/groups/public/ documents/CPSI/UNPAN027810.pdf >(2007).
19. Séguin, B., Hardy, B., Singer, P A. and Daar, A. S.: Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN). Nature Rev. Genet. 9 (Suppl), S5-S9 (2008).